Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients.
Zi-Li HuXuqi SunJie MeiZhiwen HuZiliang YangJingyu HouYizhen FuXiao-Hui WangMinshan ChenPublished in: Journal of hepatocellular carcinoma (2022)
Antiviral treatments could eliminate the adverse impacts of high HBV loads on the survival of HCC patients. Simplified eligibility criteria can be adopted for HCC patients with HBV infection where regular antiviral therapy should be enough.